Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    2011577 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed HAT in Eye Complications of Behcet's Disease
Conditions: Behcet's Syndrome;   Retinal Disease;   Uveitis
Intervention: Drug: Daclizumab
2 Completed ANTI-TAC THERAPY FOR UVEITIS
Condition: Uveitis
Intervention: Drug: Daclizumab (Zenapax)

Indicates status has not been verified in more than two years